Categories: CareHealthTechMedtechTechnology
Rejoni is a privately held medical technology company designing and developing hydrogels to improve the standard of care in Women’s Health.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.12.2022 | Series B | $25M | - |
Mentions in press and media 4
| Date | Title | Description |
| 04.02.2025 | Rejoni completes patient enrollment in pivotal clinical study of a Novel Treatment for the Prevention of Intrauterine Adhesions, the Juveena® Hydrogel System. | BEDFORD, Mass.–(BUSINESS WIRE)–February 4, 2025–
Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study. This announcement marks a s... |
| 07.12.2022 | Rejoni Closes $25M Series B Financing | Rejoni, a Bedford, MA-based company focused on the development and commercialization of gynecological products using its proprietary biomaterials, raised $25M in Series B funding.
The round was led by Catalyst Health Ventures, with continue... |
| 14.09.2020 | Rejoni Closes $15 Million Financing | Rejoni announced today that it has closed a $15 million Series A financing. The round was led by Ascension Ventures, with additional participation from Delos Capital and Sparta Group.
Rejoni is using its biomaterials expertise to realize me... |
| - | Rejoni | “Rejoni – Focused on helping women achieve the life they want” |
Reviews 0
